Agios Pharmaceuticals | AGIO - Operating Profit

Stock Price
27.78
Daily Change
-0.15 -0.54%
Monthly
1.20%
Yearly
-19.20%
Q1 Forecast
26.59

Agios Pharmaceuticals reported $-116.87M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 4.58B 1.13B Sep/2025
Agios Pharmaceuticals USD -116.87M 10.19M Sep/2025
Alnylam Pharmaceuticals USD -29.96M 13.76M Sep/2025
Amgen USD 3.96B 464M Dec/2025
Arrowhead Research USD 44.11M 209.66M Sep/2025
Astellas Pharma JPY 104.41B 11.87B Sep/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
Bayer EUR -543M 556M Sep/2025
Biogen USD 659.6M 192.2M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Eli Lilly USD 8.39B 1.37B Sep/2025
Exelixis USD 256.36M 42.78M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
GlaxoSmithKline GBP 2.79B 764M Sep/2025
Incyte USD 431.31M 120.49M Sep/2025
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
Merck USD 6.24B 318M Dec/2025
Moderna USD -260M 647M Sep/2025
Novartis USD 4.5B 363M Sep/2025
Novartis USD 4.58B 879M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Vertex Pharmaceuticals USD 1.24B 84.6M Sep/2025